Salto Partners

  • Home
  • About
  • Services
    • Board Advisory Services
    • Corporate Governance
    • Sales Excellence
  • Verticals
    • Technology
    • Life Sciences
    • Privately Held Companies
  • Blog
  • Contact

Market Analysis

Life Sciences is a broad category encompassing the range of industries driven by the biological sciences. This range runs from basic laboratory research tools and services through applications in medicine, agriculture, and even some aspects of environmental and materials sectors. By far the biggest industries in the life sciences category are related to human healthcare, including pharmaceuticals; diagnostics; medical devices; and healthcare facilities, delivery, policy and financing. Although heavily regulated in most parts of the globe, human healthcare continues to be a high-growth and often high-margin sector driven by technological innovation, ever-increasing demand, and well-developed funding and public sector support. It is not unusual for breakthrough products in this sector to experience explosive double- and triple-digit growth in their early years, and even products and services that are mere commodities in other markets can find premium value when associated with clinical applications. Despite this luring promise, the complex regulatory, technological, and financial dynamics of this sector make it one of the most challenging to manufacturers and marketers. There is an unlimited the desire to improve processes, pick up speed in R&D, enhance sales. This is a perfect opportunity for companies offering disruptive technologies and services. Salto Partners helps you to assess the potential of your company’s value proposition.

Social Media

  • Email
  • Facebook
  • LinkedIn
  • Twitter

Five Key Phases of a Turnaround

Turnarounds are not for the fainthearted among us.  Turning around a troubled entity is complex. There are many stakeholders: a nervous board, a thin-skinned management team and worried employees are just the beginning. There are customers who might run for the exits, partners second guessing their alliances. Public companies need to deal with the stock market expectations while […]

Bubble 2.0: Is It Happening Again?

Facebook bought Instagram for $1 billion. It paid that kind of money for a photo sharing app that can be used for free. Instagram has no revenue. For those of us who have been around the block for a while, deals like this are like déjà vu. We have seen this all before, way back […]

Lessons Learned from the Facebook IPO

After months of media hype we sobered up rather quickly. The Facebook IPO revealed some surprising lessons learned about the US stock market system. We learned that the NASDAQ, a trading platform that is in business since 1971 and that supposedly has more trading volume than any other electronic stock exchange in the world, can […]

Copyright © 2026 · Executive Pro Theme on Genesis Framework · WordPress · Log in